Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid

Cellular Physiology and Biochemistry

Volumn 14, Issue 3, 2004, Pages 167-176

  Gouni Berthold, Ioanna ^a,b   Seewald, Stefan ^a   Hescheler, Jürgen ^b   Sachinidis, Agapios ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ERK1 2; LDL; LPA; p38 map kinase; SAPK; VSMC

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM ION; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTUSSIS TOXIN; STRESS ACTIVATED PROTEIN KINASE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 2342564514     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078108     Document Type: Article

References (55)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Blenis J: Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci U S A 1993;90:5889-5892.
3. Cobb M, Goldsmith E: How MAP kinases are regulated. J Biol Chem 1995;270:14843-14846.
4. Davis RJ: MAPKs: new JNK expands the group. Trends Biochem Sci 1994;19:470-473.
5. Nishida E, Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 1993;18:128-131.
6. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-1037.
7. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-811.
8. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
9. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268:14553-14556.
10. Kyriakis JM, Avruch J: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313-24316.
11. Robinson MJ, Cobb MH: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9:180-186.
12. Gonzales F, Seth A, Raden D, Bowman D, Fay F, Davis R: Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 1993;122:1089-1101.
13. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J: Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapk) in fibroblasts. J Cell Biol 1993;122:1079-1088.
14. 4 Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 1995;9:726-735.
15. Treisman R: Journey to the surface of the cell: fos regulation and the SRE. EMBO J 1995;14:4905-4913.
16. Treisman R: Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996;8:205-215.
17. Force T, Bonventre JV: Growth factors and mitogen-activated protein kinases. Hypertension 1998;31:152-161.
18. Yin T, Sandhu G, Wolfgang C, Burrier A, Webb R, Rigel D, Hai T, Whelan J: Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997;1997:19943-19950.
19. Duff J, Monia B, Berk B: Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effects of actinomycin D and antisense oligonucleotides. J Biol Chem 1995;270:7161-7166.
20. 0 Sun H, Charles C, lau L, Tonks N: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 1993;75:487-493.
21. Sun H, Tonks N, Bar-Sagi D: Inhibition of Ras-induced DNA synthesisby expression of the phosphatase MKP-1. Science 1994;266:285-288.
22. Ward Y, Gupta S, Jensen P, Wartmann M, Davis R, Kelly K: Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 1994;367:651-654.
23. Chu Y, Solski P, Khosravi-Far R, Der C, Kelly K: The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem 1996;271:8377-8380.
24. 4 Liu Y, Gorospe M, Yang C, Holbrook N: Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. inhibition of c-jun N-terminal kinase and AP-1-dependent gene activation. J Biol Chem 1995;270:8377-8380.
25. Kost C, Herzer W, Li P, Jackson E: Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1999;26:449-455.
26. 6 Sachinidis A, Seewald S, Epping P, Seul C, Ko Y, Vetter H: The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol Pharmacol 1997;52:389-397.
27. 7 Seewald S, Sachinidis A, Düsing R, Ko Y, Seul C, Epping P, Vetter H: Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells. Atherosclerosis 1997;130:121-131.
28. 8 Chamley JH, Campbell GR, Ross R: The smooth muscle cell in culture. Physiol Rev 1979;39:1-61.
29. 9 Sachinidis A, Flesch M, Ko Y, Schrör K, Böhm M, Düsing R, Vetter H: Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension 1995;26:771-780.
30. Redgrave TG, Roberts DC, West CE: Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 1975;65:42-49.
31. Ko Y, Totzke G, Seewald S, Schmitz U, Schiermeyer B, Meyer zu Brickwedde M, Vetter H, Sachinidis A: Native low-density lipoprotein (LDL) induces the expression of the early-growth response gene-1 in human umbilical arterial endothelial cells. Eur J Cell Biol 1995;68:306-312.
32. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
33. Bokemeyer D, Sorokin A, Dunn MJ: Differential regulation of the dual-specificity protein-tyrosine phosphatases CL100, B23, and PAC1 in mesangial cells. J Am Soc Nephrol 1997;8:40-50.
34. Koch W, Hawes B, Allen L, Lefkowitz R: Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. Proc Natl Acad Sci U S A 1994;91:12706-12710.
35. Crespo P, Xu N, Simonds W, Gutkind J: Ras-dependent activation of MAP kinasepathway mediated by G-protein beta gamma subunits. Nature 1994;369:418-420.
36. Faure M, Voyno-Yasenetskaya TA, Bourne HR: cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 1994;269:7851-7854.
37. 7 Hawes B, van Biesen t, Koch W, Luttrell L, Lefkowitz R: Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 1995;270:17148-17153.
38. Yamauchi J, Nagao M, Kaziro Y, Itoh H: Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbettagamma and Galphaq/11 subunits. J Biol Chem 1997;272:27771-27777.
39. Coso O, Teramoto H, Simond W, Gutkind J: Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway. J Biol Chem 1996;271:3963-3966.
40. Iaccarino G, Smithwick L, Lefkowitz R, Koch W: Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. Proc Natl Acad Sci U S A 1999;96:3945-3950.
41. Sachinidis A, Kettenhofen R, Seewald S, Gouni-Berthold I, Schmitz U, Seul C, Ko Y, Vetter H: Evidence that lipoproteins are carriers of bioactive factors. Arterioscl Thromb Vasc Biol 1999;19:2412-2421.
42. Siess W, Zangl K, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M: Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A 1999;96:6931-6936.
43. Cui M, Penn M, Chisolm G: Native and oxidized low density lipoprotein induction of tissue factor gene expression insmooth muscle cells is mediated by both Egr-1 and Sp1. J Biol Chem 1999;274:32795-32802.
44. Cui M-Z, Zhao G, Winokur A, Laag E, Bydash J, Penn M, Chisolm G, Xu X: Lysophosphatidic acid induction of tissue factor expression in aortic smooth muscle cells. Arterioscler Thromb 2003;23:224-230.
45. Pages G, Lenormand P, L.Allemain G, Chambard JC, Meloche S, Pouyssegur J: Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A 1993;90:8319-8323.
46. Sewing A, Wiseman B, Lloyd A, Land H: High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biochem 1997;17:5588-5597.
47. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M: Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biochem 1997;17:5598-5597.
48. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K: Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 2001;89:251-258.
49. Cook S, Beltman J, Cadwallader K, McMahon M, McCormick F: Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J Biol Chem 1997;272:13309-13319.
50. 0 Metzler B, Li C, Hu Y, Sturm G, Ghaffari-Tabrizi N, Xu Q: LDL stimulates mitogen-activated protein kinase phosphatase-1 expression, independent of LDL receptors, in vascular smooth muscle cells. Arterioscl Thromb Vasc Biol 1999;19:1862-1871.
51. Xu Y, Rathi S, Chapman D, Arneja A, Dhalla N: Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells. J Cardiovasc Pharmacol 2003;41:381-387.
52. Seewald S, Seul C, Kettenhofen R, bokemeyer D, Ko Y, Vetter H, Sachinidis A: Role of mitogen-activated protein kinase in the angiotensin II-induced DNA synthesis in vascular smooth muscle cells. Hypertension 1998;31:1151-1156.
53. Jing Q, Xin SM, Cheng ZJ, Zhang WB, Zhang R, Qin YW, Pei G: Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxity. Circ Res 1999;84:831-839.
54. Gouni-Berthold I, Sachinidis A. Do the coronary risk factor low-density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J 2002;16:1477-1487
55. 5 Singh R, Dhawan P, Golden C, Kapoor G, Mehta K: One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/ 44(MAPK) cascade. J Biol Chem 1999;274:19593-19600.